Universal Health Services, Inc. Class B (UHS) is a publicly traded Healthcare sector company. As of May 21, 2026, UHS trades at $165.30 with a market cap of $10.25B and a P/E ratio of 6.82. UHS moved -1.22% today. Year to date, UHS is -26.27%; over the trailing twelve months it is -16.05%. Its 52-week range spans $152.33 to $246.33. Analyst consensus is buy with an average price target of $225.92. Rallies surfaces UHS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
UHS jumps as Q1 beat and reaffirmed 2026 volume targets fuel rebound bid: Universal Health Services (UHS) is rising after its first-quarter 2026 results beat consensus expectations and management reiterated full-year 2026 volume targets despite weather- and seasonality-driven softness early in the year. Investors are also positioning ahead of UHS’s May 20, 2026 virtual annual meeting amid upbeat second-half volume commentary.
| Metric | Value |
|---|---|
| Price | $165.30 |
| Market Cap | $10.25B |
| P/E Ratio | 6.82 |
| EPS | $24.27 |
| Dividend Yield | 0.20% |
| 52-Week High | $246.33 |
| 52-Week Low | $152.33 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $17.76B |
| Net Income | $1.55B |
| Gross Margin | 0.00% |
13 analysts cover UHS: 0 strong buy, 5 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $225.92.